- Home
- TNDM
as 12-17-2024 4:00pm EST
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | San Diego |
| Market Cap: | 1.9B | IPO Year: | 2013 |
| Target Price: | $52.06 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Buy | Number of Analysts: | 16 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.94 | EPS Growth: | N/A |
| 52 Week Low/High: | $21.85 - $53.69 | Next Earning Date: | 11-06-2024 |
| Revenue: | $854,351,000 | Revenue Growth: | 10.75% |
| Revenue Growth (this year): | 23.98% | Revenue Growth (next year): | 10.89% |
Stock Insider Trading Activity of Tandem Diabetes Care Inc. (TNDM)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| BLICKENSTAFF KIM D | TNDM | Director | Nov 20 '24 | Sell | $30.69 | 40,000 | $1,241,400.00 | 195,190 | |
| Novara Mark David | TNDM | EVP & CHIEF COMMERCIAL OFFICER | Nov 15 '24 | Buy | $23.24 | 532 | $12,363.68 | 532 |
Latest Tandem Diabetes Care Inc. News
TNDM Breaking Stock News: Dive into TNDM Ticker-Specific Updates for Smart Investing
Zacks
5 days ago
TNDM Stock to Gain From t:slim X2 With Dexcom G7 Launch in Canada
Argus Research
8 days ago
TNDM: What does Argus have to say about TNDM?
Business Wire
8 days ago
Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada
Zacks
12 days ago
Tandem Diabetes Care (TNDM) Down 9.2% Since Last Earnings Report: Can It Rebound?
Zacks
12 days ago
Reasons to Retain TNDM Stock in Your Portfolio for Now
Argus Research
15 days ago
TNDM: Raising target price to $27.00
Argus Research
22 days ago
TNDM: Raising target price to $24.00
Insider Monkey
22 days ago
Tandem Diabetes Care, Inc. (TNDM): An Oversold Healthcare Stock to Invest In Now
Compare TNDM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TNDM Tandem Diabetes Care Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.